We are committed to the development and commercialization of first-in-class treatment options to improve the lives of patients and caregivers.
Ironshore's mission is to commercialize innovative, patient-focused treatment options to improve the lives of patients and caregivers.
Learn more about our proprietary, oral controlled-release technology for evening dosing of medication with delayed- and extended-release characteristics.
Our proprietary technologies enable precision targeting of medication to address a significant unmet medical need.
View our webinars, press releases, and publications and track the progress of our pharmaceutical products.
Get the latest company updates on our products and marketing news.
Sign-Up
Get the latest company updates on our products and marketing news.
© 2023 Ironshore Pharmaceuticals, Inc. | IP001327 09/22 | Site Design: Digital Elevator